213 related articles for article (PubMed ID: 32429317)
1. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
[TBL] [Abstract][Full Text] [Related]
3. Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.
Yousuf M; Shamsi A; Queen A; Shahbaaz M; Khan P; Hussain A; Alajmi MF; Rizwanul Haque QM; Imtaiyaz Hassan M
J Cell Biochem; 2021 Aug; 122(8):897-910. PubMed ID: 33829554
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
[TBL] [Abstract][Full Text] [Related]
5. Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics.
Yousuf M; Shamsi A; Khan S; Khan P; Shahwan M; Elasbali AM; Haque QMR; Hassan MI
Int J Biol Macromol; 2022 Jul; 213():944-954. PubMed ID: 35690164
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
Yousuf M; Khan P; Shamsi A; Shahbaaz M; Hasan GM; Haque QMR; Christoffels A; Islam A; Hassan MI
ACS Omega; 2020 Oct; 5(42):27480-27491. PubMed ID: 33134711
[TBL] [Abstract][Full Text] [Related]
7. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
Khuntawee W; Rungrotmongkol T; Hannongbua S
J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
[TBL] [Abstract][Full Text] [Related]
8. Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase.
Gulzar M; Syed SB; Khan FI; Khan P; Ali S; Hasan GM; Taneja P; Hassan MI
Int J Biol Macromol; 2019 Feb; 122():1297-1304. PubMed ID: 30227205
[TBL] [Abstract][Full Text] [Related]
9. Reduced state transition barrier of CDK6 from open to closed state induced by Thr177 phosphorylation and its implication in binding modes of inhibitors.
He H; Xu J; Xie W; Guo QL; Jiang FL; Liu Y
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):501-512. PubMed ID: 29108955
[TBL] [Abstract][Full Text] [Related]
10. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
Wang N; Wang ZY; Mo SL; Loo TY; Wang DM; Luo HB; Yang DP; Chen YL; Shen JG; Chen JP
Breast Cancer Res Treat; 2012 Aug; 134(3):943-55. PubMed ID: 22350787
[TBL] [Abstract][Full Text] [Related]
11. Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity.
Yousuf M; Khan S; Hussain A; Alajmi MF; Shamsi A; Haque QMR; Islam A; Hassan MI
Int J Biol Macromol; 2024 Apr; 264(Pt 2):130624. PubMed ID: 38453105
[TBL] [Abstract][Full Text] [Related]
12. Ellagic acid inhibits human glioblastoma growth in vitro and in vivo.
Wang D; Chen Q; Tan Y; Liu B; Liu C
Oncol Rep; 2017 Feb; 37(2):1084-1092. PubMed ID: 28035411
[TBL] [Abstract][Full Text] [Related]
13. C-glycosyl flavone from
Bevara GB; Naveen Kumar AD; Koteshwaramma KL; Badana A; Kumari S; Malla RR
Indian J Med Res; 2018 Feb; 147(2):158-168. PubMed ID: 29806604
[TBL] [Abstract][Full Text] [Related]
14. Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity.
Li Q; Chen L; Ma YF; Jian XE; Ji JH; You WW; Zhao PL
Bioorg Chem; 2021 Nov; 116():105324. PubMed ID: 34509794
[TBL] [Abstract][Full Text] [Related]
15. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
[TBL] [Abstract][Full Text] [Related]
16. Discovery and SARs of 5-Chloro-
Wang Y; Chen X; Yan Y; Zhu X; Liu M; Liu X
J Med Chem; 2020 Mar; 63(6):3327-3347. PubMed ID: 32129996
[TBL] [Abstract][Full Text] [Related]
17. A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations.
Susanti NMP; Damayanti S; Kartasasmita RE; Tjahjono DH
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948218
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics.
Yousuf M; Shamsi A; Mohammad T; Azum N; Alfaifi SYM; Asiri AM; Mohamed Elasbali A; Islam A; Hassan MI; Haque QMR
ACS Omega; 2022 Jul; 7(29):25844-25852. PubMed ID: 35910117
[TBL] [Abstract][Full Text] [Related]
19. Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.
Cheshomi H; Bahrami AR; Matin MM
Mol Divers; 2021 Feb; 25(1):333-349. PubMed ID: 32410114
[TBL] [Abstract][Full Text] [Related]
20. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]